Exosomes and immune surveillance of neoplastic lesions: a review

References

• Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, Min WP (2005) Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol. Dis. 35: 169–173.
   PubMed Web of Science ®Google Scholar
• Admyre C, Bohle B, Johansson SM, Focke-Tejkl M, Valenta R, Scheynius A, Gabrielsson S (2007) B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J. Allerg. Clin. Immunol. 120: 1418–1424.
   PubMed Web of Science ®Google Scholar
• Andr F, Schartz NE, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L (2002a) Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 20, Suppl 4: A28–A31.
   Google Scholar
• Andr F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L (2002b) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295–305.
   Google Scholar
• Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M (2008) B cell activation regulates exosomal HLA production. Eur. J. Immunol. 38: 1423–1434.
   Web of Science ®Google Scholar
• Blanc L, Barres C, Bette-Bobillo P, Vidal M (2007) Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2. Blood 110: 3407–3416.
   Web of Science ®Google Scholar
• Buschow SI, Nolte-'t Hoen EN, van Niel G, Pols MS, ten Broeke T, Lauwen M, Ossendorp F, Melief CJ, Raposo G, Wubbolts R, Wauben MH, Stoorvogel W (2009) MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10: 1528–1542.
   PubMed Web of Science ®Google Scholar
• Chaput N, Taïeb J, Schartz NEC, Andr F, Angevin E, Zitvogel L (2004). Exosome-based immunotherapy. Cancer Immunol. Immunother. 53: 234–239.
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Wojciechowski J, Tainsky MA (2009) Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput. Methods Mol. Biol. 520: 21–38.
   PubMedGoogle Scholar
• Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, Cao X (2006) Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur. J. Immunol. 36: 1598–1607.
   PubMed Web of Science ®Google Scholar
• Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B (2001) Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 247: 163–174.
   PubMed Web of Science ®Google Scholar
• Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16: 782–790.
   PubMed Web of Science ®Google Scholar
• Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, Geuze HJ (2000) Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol. 165: 1259–1265.
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, Andr F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med. 3: 10.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162–174.
   PubMed Web of Science ®Google Scholar
• Gauvreau ME, Côté MH, Bourgeois-Daigneault MC, Rivard LD, Xiu F, Brunet A, Shaw A, Steimle V, Thibodeau J (2009) Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. Traffic 10: 1518–1527.
   PubMed Web of Science ®Google Scholar
• Grizzle WE, Mountz JD, Yang PA, Xu X, Sun S, Van Zant GE, Williams RW, Hsu HC, Zhang HG (2002) BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model. Int. J. Cancer 101: 270–279.
   PubMedGoogle Scholar
• Herberman RB (1995) Potential role of natural antibodies in resistance to tumor growth. Nat. Immun. 14: 1.
   Google Scholar
• Hsu DH, Paz P, Villaflor G, Rivas A, Mehta-Damani A, Angevin E, Zitvogel L, Le Pecq JB (2003) Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J. Immunother. 26: 440–450.
   PubMed Web of Science ®Google Scholar
• Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L (2008) Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15: 80–88.
   PubMed Web of Science ®Google Scholar
• Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2005) Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum. 52: 1517–1521.
   PubMed Web of Science ®Google Scholar
• Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD (2007) MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner. J. Immunol. 179: 2235–2241.
   PubMedGoogle Scholar
• Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, Nash J, Mi Z, Watkins SC, Gambotto A, Robbins PD (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174: 6440–6448.
   PubMed Web of Science ®Google Scholar
• Kleijmeer MJ, Escola JM, Uytde Haag FG, Jakobson E, Griffith JM, Osterhaus AD, Stoorvogel W, Melief CJ, Rabouille C, Geuze HJ (2001) Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2: 124–137.
   PubMed Web of Science ®Google Scholar
• Koss LG (1979) Diagnosis of early endometrial cancer and precancerous states. Ann. Clin. Lab. Sci. 9: 189–194.
   Google Scholar
• Lin F, Zhang PL, Yang XJ, Shi J, Blasick T, Han WK, Wang HL, Shen SS, Teh BT, Bonventre JV (2007) Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am. J. Surg. Pathol. 31: 371–381.
   PubMed Web of Science ®Google Scholar
• Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG (2007) Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109: 4336–4342.
   PubMed Web of Science ®Google Scholar
• Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176: 1375–1385.
   PubMed Web of Science ®Google Scholar
• Lu Q, Zhang J, Allison R, Gay H, Yang WX, Bhowmick NA, Frelix G, Shappell S, Chen YH (2009) Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate 69: 411–418.
   PubMed Web of Science ®Google Scholar
• Luketic L, Delanghe J, Sobol PT, Yang P, Frotten E, Mossman KL, Gauldie J, Bramson J, Wan Y (2007) Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J. Immunol. 179: 5024–5032.
   Web of Science ®Google Scholar
• Lynch S, Santos SG, Campbell EC, Nimmo AM, Botting C, Prescott A, Antoniou AN, Powis SJ (2009) Novel MHC class I structures on exosomes. J. Immunol. 183: 1884–1891.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Simpson RJ (2009) ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9: 4997–5000.
   PubMed Web of Science ®Google Scholar
• Poliakov A, Spilman M, Dokland T, Amling CL, Mobley JA (2009) Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 69: 159–167.
   PubMed Web of Science ®Google Scholar
• Sabapatha A, Gercel-Taylor C, Taylor DD (2006) Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am. J. Reprod. Immunol. 56: 345–355.
   PubMed Web of Science ®Google Scholar
• Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 63: 4331–4337.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Akyol S, Gercel-Taylor C (2006) Pregnancy-associated exosomes and their modulation of T cell signaling. J. Immunol. 176: 1534–1542.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C (2005) Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92: 305–311.
   PubMed Web of Science ®Google Scholar
• Chaput N, Taïeb J, Schartz NEC, Andr F, Angevin E, Zitvogel L (2004). Exosome-based immunotherapy. Cancer Immunol. Immunother. 53: 234–239.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C, Parker LP (2009) Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol. Oncol. 1: 112–120
   Google Scholar
• Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581–593.
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2: 569–579.
   PubMed Web of Science ®Google Scholar
• Utsugi-Kobukai S, Fujimaki H, Hotta C, Nakazawa M, Minami M (2003) MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol. Lett. 89: 125–131.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE (2006) Cancer incidence before and after kidney transplantation. JAMA 296: 2823–2831.
   PubMed Web of Science ®Google Scholar
• Viaud S, Terme M, Flament C, Taieb J, Andr F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N (2009) Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One 4: e4942.
   PubMed Web of Science ®Google Scholar
• Vicari AP, Caux C, Trinchieri G (2002) Tumour escape from immune surveillance through dendritic cell inactivation. Semin. Cancer Biol. 12: 33–42.
   PubMed Web of Science ®Google Scholar
• Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, Pain S, Raposo G, Benaroch P, Bonnerot C. (2002) Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int. Immunol. 14: 713–722.
   PubMed Web of Science ®Google Scholar
• Wang GJ, Liu Y, Qin A, Shah SV, Deng ZB, Xiang X, Cheng Z, Liu C, Wang J, Zhang L, Grizzle WE, Zhang HG (2008) Thymus exosomes-like particles induce regulatory T cells. J. Immunol. 181: 5242–5248.
   PubMed Web of Science ®Google Scholar
• Weber K, Doucet M, Kominsky S (2007) Renal cell carcinoma bone metastasis-elucidating the molecular targets. Cancer Metastasis Rev. 26: 691–704.
   PubMed Web of Science ®Google Scholar
• Whiteside TL (2005) Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Br. J. Cancer 92: 209–211.
   PubMed Web of Science ®Google Scholar
• Whiteside TL, Herberman RB (1995) The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7: 704–710.
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7: 297–303.
   PubMed Web of Science ®Google Scholar
• Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J, Cheng Z, Shah SV, Wang GJ, Zhang L, Grizzle WE, Mobley J, Zhang HG. (2009) Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer 124: 2621–2633.
   Google Scholar
• Xiu F, Cai Z, Yang Y, Wang X, Wang J, Cao X (2007) Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes. J. Mol. Med. 85: 511–521.
   PubMed Web of Science ®Google Scholar
• Yu S, Liu C, Su K, Wang J, Liu Y, Zhang L, Li C, Cong Y, Kimberly R, Grizzle WE, Falkson C, Zhang HG (2007) Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J. Immunol. 178: 6867–6875.
   PubMed Web of Science ®Google Scholar
• Yu X, Harris SL, Levine AJ (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66: 4795–4801.
   PubMed Web of Science ®Google Scholar
• Yu X, Riley T, Levine AJ (2009) The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS 276: 2201–2212.
   PubMedGoogle Scholar
• Zhang HG, Grizzle WE (2003) Aging, immunity, and tumor susceptibility. Immunol. Allergy Clin. North Am. 23: 83–102, vi.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Kim H, Liu C, Yu S, Wang J, Grizzle WE, Kimberly RP, Barnes S (2007) Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim. Biophys. Acta 1773: 1116–1123.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Liu C, Su K, Yu S, Zhang L, Zhang S, Wang J, Cao X, Grizzle W, Kimberly RP (2006) A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. J. Immunol. 176: 7385–7393.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594–600.
   PubMed Web of Science ®Google Scholar